-
-
-
-
-
-
-
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates
-
-
-
-
-
-
-
Heron Therapeutics (HRTX) PT Lowered to $13 at Cowen
-
-
-
-
-
-
-
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/20: (IOTS) (STMP) (ETFC) Higher (TVTY) (SIX) (OSUR) Lower (more...)
-
-
-
-
-
-
-
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain
-
-
-
-
-
-
-
Bullish Options Activity in Heron Therapeutics (HRTX) Targets Upside in Shares Ahead of Upcoming Catalysts -Susquehanna
-
-
-
-
-
-
-
Heron Therapeutics Announces Retirement of Robert Rosen as President
-
12,349 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All